Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 8, 2026, 3:40 PM EST
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $56.2 thousand as of July 9, 2026. Its market cap has decreased by -96.13% in one year.
Market Cap
56.20K
Enterprise Value
1.03M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 56.20K, a decrease of -99.72%. That is a compound annual growth rate of -39.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 56.20K | -92.97% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigyn Therapeutics | 101.72K |
| Nascent Biotech | 86.42K |
| Affymax | 74.49K |
| Ocean Biomedical | 69.71K |
| Scorpius Holdings | 67.26K |
| Vincerx Pharma | 66.48K |
| U.S. Stem Cell | 66.15K |
| PaxMedica | 63.14K |